Pre-operative GnRH agonists in deep endometriosis: insights beyond the current evidence

Shahar Bano, Hira Shehzad, Sarmad Nazir
Facts, views & vision in ObGyn · 2025 · vol. 17(3) , pp. 298–299 · doi:10.52054/FVVO.2025.206 · PMID:40981682 · PMC12489270
other OA: gold CC-BY-NC-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-23 ⓘ

This paper provides insights into the use of pre-operative GnRH agonists for deep endometriosis that extend beyond current evidence, although specific findings are not detailed in the provided text.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-12T06:55:35.949492+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-09-12T06:50:23.311080+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: CC-BY-NC-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine